Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease? - Wikidata - awgldk - TriplyDB

Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?

Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?

http://www.wikidata.org/entity/Q35640718

about

The H2S Donor NaHS Changes the Expression Pattern of H2S-Producing Enzymes after Myocardial Infarction Hydrogen Sulfide Mitigates Kidney Injury in High Fat Diet-Induced Obese Mice.Hydrogen sulfide inhibits epithelial-mesenchymal transition in peritoneal mesothelial cells.

P2860

Q36530419-C3314A5A-ACDA-4875-BEDF-5C662C8FF2AD Q37060073-A8B80C20-8BCA-4C51-8A2B-815A9105C747 Q55001323-2127702F-D5FE-411E-BACD-4E117EE57617

P2860

Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?

http://www.wikidata.org/entity/Q35640718

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?

@ast

Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?

@en

type

label

Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?

@ast

Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?

@en

prefLabel

Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?

@ast

Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?

@en

P1433

Q35640718-A1D7FA9B-48FD-4C88-BEF6-1C5F470AF07B

P1476

Q35640718-AE9A3BD8-FF09-4F97-90A6-C070B482C771

P2093

Q35640718-0A98C860-86F1-404F-A229-524F46F7E280

Q35640718-42968F82-7116-4F18-AED7-FDCB45FFF811

Q35640718-55D2693F-7A0F-4753-B263-0BC6FFA89BE9

Q35640718-DB91C1E7-9542-4414-89A1-FE39CE15360A

Q35640718-E9150744-27D6-466B-ADF1-E9123BB49A1D

P275

Q35640718-A8B9438F-77F9-467E-8868-43CA0CC630D5

P2860

Q35640718-05E74F6E-1658-439B-A50D-E97A980C49B0

Q35640718-0718E828-1043-4D19-A51F-F60DB9DDDF86

Q35640718-075AF490-620F-465B-8102-70AA62B693D4

Q35640718-0952F8B8-10EF-49C3-87A6-4D9BC08F1A52

Q35640718-0B13980D-0933-457D-9363-DAD1B38BB5C4

Q35640718-0B82F3F6-52BC-47BC-8D4F-AF04464CEB4A

Q35640718-0CA6B26E-9416-431D-8183-115B66436633

Q35640718-127CAFF4-FEB1-4A74-B9B9-6F3BAC3EBA01

Q35640718-1BA857B4-EA9D-4D4D-9336-F9391407677F

Q35640718-204B29C5-F84C-4AAF-A803-D2964FACCC25

P304

Q35640718-CEB2B311-2ABF-4FD4-98C4-B9CFE0740925

P31

Q35640718-4114921B-D39D-49DA-85D0-A4B19EADA785

Q35640718-A86BAD64-2A26-4161-9011-B3631B302BBA

P356

Q35640718-612F1445-D087-4AD9-9158-707E7B753836

P478

Q35640718-7880CC18-B1F3-4BA6-8BEE-FC7D092E6663

P50

Q35640718-D0BA26C2-9270-48AF-8AB4-FD8D5D9E94DE

P5008

Q35640718-3FFE574A-4DC8-478F-80CB-47C5A337762B

P577

Q35640718-E8D1085D-B2DF-4396-8CFE-E57ED9EB9CD6

P5875

Q35640718-7492EBC2-BFAF-4F65-9113-946063E3DB97

P698

Q35640718-788B6ED6-78B1-49CB-9548-35CC760971A6

P921

Q35640718-0AA686C9-842C-487E-A8A0-5044AAE5477A

Q35640718-7D10CC92-6631-4B0A-BF05-FB8DDDB3E793

Q35640718-B213EEDC-5803-446F-B60F-4DD02EF78784

Q35640718-BB4FAFD5-C816-41CC-90BE-A331E8031974

Q35640718-FB5FF777-5EA6-4349-9D3C-8B52628DDBA5

P932

Q35640718-243DB869-6625-4547-B6AF-D84F2A4C9D4F

P356

P1433

Oxidative medicine and cellular longevity

P1476

Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?

@en

P2093

Kai Song

http://www.w3.org/2001/XMLSchema#string

Li-Fang Hu

http://www.w3.org/2001/XMLSchema#string

Qian Li

http://www.w3.org/2001/XMLSchema#string

Xiao-Ya Yin

http://www.w3.org/2001/XMLSchema#string

Ying Lu

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase

Adiponectin regulates albuminuria and podocyte function in mice

Cellular and molecular mechanisms of fibrosis

H2S induces a suspended animation-like state in mice

The MAM (meprin/A5-protein/PTPmu) domain is a homophilic binding site promoting the lateral dimerization of receptor-like protein-tyrosine phosphatase mu

Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia

Monocyte and macrophage heterogeneity

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

P304

458720

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/458720

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2015-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277343876

http://www.w3.org/2001/XMLSchema#string

P698

26078807

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

inorganic compound

idiopathic pulmonary fibrosis

mechanism of action

chronic kidney disease

P932

4442291

http://www.w3.org/2001/XMLSchema#string